Actively Recruiting
The Feasibility and the Efficacy of the Full-immersive Virtual Reality Cognitive Training in Patients With Mild or Moderate Dementia
Led by Chang Gung Memorial Hospital · Updated on 2025-06-24
30
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This project will explore the feasibility and efficacy of the fully immersive virtual reality leisure cognitive training tool developed by Chang Gung University in patients with mild to moderate dementia. The feasibility study will assess the feasibility and emotion-related indicators of 10 patients before and after a single training session. The efficacy study is planned to adopt a crossover randomized controlled trial, recruiting 30 patients for 15 sessions, each lasting 65 minutes, conducted three times a week. The assessment will include tests on the primary variable of cognitive function and secondary variables such as activities of daily living, quality of life, emotion, clinical symptoms, etc.
CONDITIONS
Official Title
The Feasibility and the Efficacy of the Full-immersive Virtual Reality Cognitive Training in Patients With Mild or Moderate Dementia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age over 55 years
- Diagnosed with mild or moderate dementia by a physician or based on medical records
- Mini-Mental State Examination (MMSE) score between 11 and 23
- Has at least one family member or regularly contacted friend reachable weekly
- Able to walk independently and complete the Timed Up & Go (TUG) test
- Able to follow instructions with or without assistance
- If moderate dementia is confirmed, must have capacity to provide informed consent or have a legal representative
You will not qualify if you...
- Dementia with Lewy Bodies or dementia caused by Huntington's Disease, substance addiction, central nervous system infections, nutritional deficiencies, or metabolic disorders
- Severe health conditions that prevent safe participation, such as respiratory distress, severe cardiovascular disease, or brain tumors
- Psychosis diagnosis within the past six months
- Diagnosis of Korsakoff syndrome
- History of substance addiction
- Severe hearing impairment or color blindness
- History of severe vertigo or epilepsy
- Participation in other studies affecting cognitive function
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Tucheng Hospital, New Taipei City, commissioned and operated by Chang Gung Medical Foundation.
New Taipei City, Taiwan
Actively Recruiting
Research Team
C
Ching-yi Wu, ScD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here